The Venture Codex Logo

The Venture Codex

Cellsource

57 West 57th Street, Suite 400, New York, 10019, United States

Overview

Biotechnology company developing cell therapy for immune tolerance.

Founded

2011

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

—

Geographic focus

Japan

Sector focus

Biotechnology
Developer Platform
Medical

Investment portfolio

1rounds
NAMEDATESIZE
Tailor App
Aug 2024Led
$2 MOther Equity
Tailor App
Aug 2024Led
$2 MOther Equity
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Cellsource: 1 funding rounds are recorded in the selected participation categories.All available history.
Cellsource: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Other Equity10

Monthly Deal Activity

Cellsource: 1 deals are recorded across 27 months.All available history.
Cellsource: 1 deals are recorded across 27 months. All available history
MonthDeals
Aug '241
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Cellsource: Marketing & Advertising is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Cellsource: Marketing & Advertising is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Marketing & Advertising1
Professional Services1

Deal Size Distribution

Cellsource: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Cellsource: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Cellsource: Japan has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Cellsource: Japan has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
Japan1
Cellsource: 1 co-investor is shown, with Lotte Ventures Japan sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Cellsource: 1 co-investor is shown, with Lotte Ventures Japan sharing 1 recorded deals. All available history
Co-investorShared deals
Lotte Ventures Japan1

Investment Strategy

Cellsource: Led accounts for 100% and participating for 0% of round participation.All available history.
Cellsource: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
Cellsource: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Cellsource: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Itamar Shimrat

CEO

Yoram Drucker

Chairman of the Board